India · Delayed Price · Currency is INR Panacea Biotec Statistics
Total Valuation
Panacea Biotec has a market cap or net worth of INR 32.85 billion. The enterprise value is 31.69 billion.
| Market Cap | 32.85B |
| Enterprise Value | 31.69B |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 61.25M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | +6.16% |
| Owned by Insiders (%) | 68.70% |
| Owned by Institutions (%) | 0.15% |
| Float | 15.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.14 |
| PB Ratio | 3.96 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 196.97 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.47 |
| Quick Ratio | 0.42 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -6.23 |
Financial Efficiency
Return on equity (ROE) is -0.86% and return on invested capital (ROIC) is -5.05%.
| Return on Equity (ROE) | -0.86% |
| Return on Assets (ROA) | -1.85% |
| Return on Invested Capital (ROIC) | -5.05% |
| Return on Capital Employed (ROCE) | -4.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.98M |
| Profits Per Employee | -24,988 |
| Employee Count | 2,149 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | -2.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +25.08% |
| 50-Day Moving Average | 420.00 |
| 200-Day Moving Average | 390.03 |
| Relative Strength Index (RSI) | 62.42 |
| Average Volume (20 Days) | 92,422 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Panacea Biotec had revenue of INR 6.40 billion and -53.70 million in losses. Loss per share was -0.88.
| Revenue | 6.40B |
| Gross Profit | 3.59B |
| Operating Income | -377.20M |
| Pretax Income | -73.70M |
| Net Income | -53.70M |
| EBITDA | -46.60M |
| EBIT | -377.20M |
| Loss Per Share | -0.88 |
Balance Sheet
The company has 744.00 million in cash and 236.60 million in debt, with a net cash position of 507.40 million.
| Cash & Cash Equivalents | 744.00M |
| Total Debt | 236.60M |
| Net Cash | 507.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.29B |
| Book Value Per Share | 128.44 |
| Working Capital | 1.64B |
Cash Flow
In the last 12 months, operating cash flow was 166.80 million and capital expenditures -540.90 million, giving a free cash flow of -374.10 million.
| Operating Cash Flow | 166.80M |
| Capital Expenditures | -540.90M |
| Depreciation & Amortization | 330.60M |
| Net Borrowing | n/a |
| Free Cash Flow | -374.10M |
| FCF Per Share | n/a |
Margins
Gross margin is 56.16%, with operating and profit margins of -5.90% and -0.84%.
| Gross Margin | 56.16% |
| Operating Margin | -5.90% |
| Pretax Margin | -1.15% |
| Profit Margin | -0.84% |
| EBITDA Margin | -0.73% |
| EBIT Margin | -5.90% |
| FCF Margin | n/a |
Dividends & Yields
Panacea Biotec does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.37% |
| Shareholder Yield | 0.37% |
| Earnings Yield | -0.16% |
| FCF Yield | -1.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |